Docetaxel trials for NSCLC (Non-small Cell Lung Cancer)

All Docetaxel trials · All NSCLC (Non-small Cell Lung Cancer) trials

Phase breakdown

Recruiting trials studying Docetaxel for NSCLC (Non-small Cell Lung Cancer)

• A Study to Evaluate GFH375 Versus Docetaxel in Participants With Non-Small Cell Lung Cancer With KRAS G12D Mutation
  NCT07668752 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure
  NCT07528274 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
  NCT06881784 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 153 locations
• WAST Cell-Docetaxel Combination Therapy in PD-1 Inhibitor-Resistant Advanced NSCLC
  NCT07330050 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Docetaxel for NSCLC (Non-small Cell Lung Cancer)?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.